Merck Gets Q1 Beat as Sales of Cancer Blockbuster Keytruda Jump 20%

cafead

Administrator
Staff member
  • cafead   Apr 25, 2024 at 12:02: PM
via Merck exceeded Wall Street expectations with 9% sales growth in the first quarter of 2024 on the strength of its oncology and vaccine products, the company announced in an earnings report Thursday.

article source
 

<